Adage Capital Management, L.P. → GLYCOMIMETICS INC CBIO

Stake: 37.00% Shares: 50,912 CUSIP: 38000Q201 Class: Ordinary Shares, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

4 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 9.73

3,743,278 shares short · +1.9% vs prior

Post-Filing Returns · since 2025-06-20 on CBIO

+1 day

+2.0%

+5 days

+20.0%

+30 days

-12.0%

+60 days

-9.3%

+90 days

-13.7%

+180 days

-16.7%

Anchor price 15.00 on closest trading day on/after 2025-06-20. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-02	Violin Jonathan	director	Award	11,050	$17.01	$188K
2026-06-02	Lubner David Charles	director	Award	11,050	$17.01	$188K
2026-06-02	Balcom Alexandra	director	Award	11,050	$17.01	$188K
2026-06-02	Moran Susan	director	Award	11,050	$17.01	$188K

Other 13D/G Filings on GLYCOMIMETICS INC

Filed	Form	Filer	Stake	Shares
2026-07-20	SCHEDULE 13D/A	Fairmount Funds Management LLC	—	6,593,385	view →

Other Filings by Adage Capital Management, L.P.

Filed	Form	Issuer	Stake	Shares
2026-07-09	SCHEDULE 13G	Nine Energy Service, Inc. NINE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →